Managers / Q2 2023 · view latest →
Bullseye Asset Management LLC
CIK 0001513779 · 8055 EAST TUFTS AVENUE, SUITE 720, DENVER, CO, 80237 · 720.545.9988
Summary
Bullseye Asset Management LLC reported $199M in U.S.-listed holdings across 70 positions for Q2 2023.
Its largest position, WING, represents 3.9% of the portfolio.
Compared with Q1 2023, the fund opened 2 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.3% · $190M
- REIT · 2.6% · $5M
- Other · 2.0% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| RBARB GLOBAL, INC. | NEW | +115.7K | 115.7K | +$7M | $7M |
| ALITALIGHT, INC. | NEW | +77.0K | 77.0K | +$712,000 | $712,000 |
| RITCHIE BROS. AUCTIONEERS INCORPORATED | SOLD OUT | −115.7K | 0 | −$7M | $0 |
| AFCGAFC GAMMA, INC. | SOLD OUT | −165.1K | 0 | −$2M | $0 |
| HCATHEALTH CATALYST, INC. | SOLD OUT | −47.0K | 0 | −$549,000 | $0 |
| EXFYEXPENSIFY, INC. | SOLD OUT | −20.8K | 0 | −$170,000 | $0 |
| ABCLABCELLERA BIOLOGICS, INC. | SOLD OUT | −17.8K | 0 | −$134,000 | $0 |
| PCORPROCORE TECHNOLOGIES INC | TRIMMED | −13.2K | 2.0K | −$821,000 | $130,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $173M | 60 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $186M | 58 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $191M | 62 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $201M | 65 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $185M | 60 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $213M | 61 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $217M | 62 | Nov 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $204M | 60 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $213M | 66 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $209M | 70 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $179M | 73 | Nov 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $199M | 70 | Aug 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $196M | 73 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $185M | 81 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $172M | 84 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $177M | 90 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $217M | 90 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $252M | 94 | Feb 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $288M | 104 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $297M | 99 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $268M | 93 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $268M | 97 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $219M | 99 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $187M | 93 | Aug 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $84M | 72 | May 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $103M | 77 | Feb 18, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.